Inpersol-zm W/ Dextrose 1.5% In Plastic Container

   
Google
 
Web NewDrugInformation.com

Inpersol-zm W/ Dextrose 1.5% In Plastic Container


Drug - Inpersol-zm W/ Dextrose 1.5% In Plastic Container
The trade name of the product as shown on the labeling.

Dosage - SOLUTION; INTRAPERITONEAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Calcium Chloride; Dextrose; Sodium Chloride; Sodium Lactate
Multiple ingredients are in alphabetical order.

Strength - 25.7MG/100ML;1.5GM/100ML;538MG/100ML;448MG/100ML
The potency of the active ingredient(s), Calcium Chloride; Dextrose; Sodium Chloride; Sodium Lactate. May repeat for multiple part products.

Applicant - FRESENIUS MEDCL
The firm name holding legal responsibility for Inpersol-zm W/ Dextrose 1.5% In Plastic Container. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019395
The FDA assigned number to Inpersol-zm W/ Dextrose 1.5% In Plastic Container. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Inpersol-zm W/ Dextrose 1.5% In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 26, 1986
The date Inpersol-zm W/ Dextrose 1.5% In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Inpersol-zm W/ Dextrose 1.5% In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Inpersol-zm W/ Dextrose 1.5% In Plastic Container is in. Format is RX, OTC, DISCN.

Applicant Full Name - Fresenius Medical Care North America
The full name of the firm holding legal responsibility for the new application of Inpersol-zm W/ Dextrose 1.5% In Plastic Container.

Inpersol-zm W/ Dextrose 1.5% In Plastic Container


Potassium Chloride 40meq In Dextrose 5% And Lactated Ringer's In Plastic Container 20mg/100ml;5gm/100ml;328mg/100ml;600mg/100ml;310mg/100ml Injectable; Injection
Potassium Chloride 40meq In Dextrose 5% And Lactated Ringer's In Plastic Container 20mg/100ml;5gm/100ml;328mg/100ml;600mg/100ml;310mg/100ml Injectable; Injection
Potassium Chloride 5meq In Dextrose 5% And Lactated Ringer's In Plastic Container 20mg/100ml;5gm/100ml;105mg/100ml;600mg/100ml;310mg/100ml Injectable; Injection
Potassium Chloride 5meq In Dextrose 5% And Lactated Ringer's In Plastic Container 20mg/100ml;5gm/100ml;104mg/100ml;600mg/100ml;310mg/100ml Injectable; Injection
Inpersol-zm W/ Dextrose 1.5% In Plastic Container 25.7mg/100ml;1.5gm/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal
Potassium Chloride 20meq In Dextrose 5% And Lactated Ringer's In Plastic Container 20mg/100ml;5gm/100ml;328mg/100ml;600mg/100ml;310mg/100ml Injectable; Injection
Potassium Chloride 20meq In Dextrose 5% And Lactated Ringer's In Plastic Container 20mg/100ml;5gm/100ml;179mg/100ml;600mg/100ml;310mg/100ml Injectable; Injection
Potassium Chloride 20meq In Dextrose 5% And Lactated Ringer's In Plastic Container 20mg/100ml;5gm/100ml;328mg/100ml;600mg/100ml;310mg/100ml Injectable; Injection
Potassium Chloride 30meq In Dextrose 5% And Lactated Ringer's In Plastic Container 20mg/100ml;5gm/100ml;254mg/100ml;600mg/100ml;310mg/100ml Injectable; Injection
Potassium Chloride 30meq In Dextrose 5% And Lactated Ringer's In Plastic Container 20mg/100ml;5gm/100ml;254mg/100ml;600mg/100ml;310mg/100ml Injectable; Injection

NewDrugInformation